Complete Filing Data
Advanced Biomed Inc. reported Common Stock Shares Issued of 20.00 million shares for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Advanced Biomed Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Research And Development Expense | $909.8K | $880.2K |
| Operating Expenses | $3.0M | $2.5M |
| Nonoperating Income Expense | -$237.9K | -$240.7K |
| Net Income Loss | -$3.3M | -$2.8M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.3M | -$2.8M |
| General And Administrative Expense | $2.1M | $1.7M |
| Comprehensive Income Net Of Tax | -$3.0M | -$2.5M |
| Other Nonoperating Income Expense | ||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $218.3K | $319.3K |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | ||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | ||
| Income Loss From Discontinued Operations Net Of Tax Per Diluted Share | ||
| Income Loss From Discontinued Operations Net Of Tax Per Basic Share | ||
| Income Loss From Discontinued Operations Net Of Tax | ||
| Income Loss From Continuing Operations Per Diluted Share | ||
| Income Loss From Continuing Operations Per Basic Share | ||
| Income Loss From Continuing Operations | ||
| Other Nonoperating Expense | $262.8K | $294.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|
| Research And Development Expense | $186.3K | $236.0K | $250.5K | $212.4K | $181.7K | $313.5K | $188.4K |
| Operating Expenses | $396.6K | $523.9K | $762.7K | $280.1K | $520.0K | $745.4K | $651.3K |
| Nonoperating Income Expense | $7.4M | $137.0K | -$621.1K | -$299.4K | $254.4K | -$310.8K | $506.0K |
| Net Income Loss | $6.9M | -$386.9K | -$1.4M | -$907.9K | -$265.6K | -$1.1M | -$145.3K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $7.0M | -$386.9K | -$1.4M | -$579.5K | -$265.6K | -$1.1M | -$145.3K |
| General And Administrative Expense | $210.3K | $287.9K | $512.3K | $67.7K | $338.3K | $431.9K | $462.9K |
| Comprehensive Income Net Of Tax | $6.5M | -$473.4K | -$1.3M | -$474.8K | -$569.4K | -$694.6K | -$608.3K |
| Other Nonoperating Income Expense | $42.9K | $136.6K | -$621.1K | -$314.8K | $254.4K | -$310.9K | $486.0K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$86.5K | $39.7K | -$303.8K | $361.6K | |||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | -$380.4K | $433.1K | |||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | $433.1K | -$463.0K | |||||
| Income Loss From Discontinued Operations Net Of Tax Per Diluted Share | -$0.01 | -$0.02 | |||||
| Income Loss From Discontinued Operations Net Of Tax Per Basic Share | -$0.01 | -$0.02 | |||||
| Income Loss From Discontinued Operations Net Of Tax | -$144.3K | -$328.4K | |||||
| Income Loss From Continuing Operations Per Diluted Share | $0.32 | -$0.03 | |||||
| Income Loss From Continuing Operations Per Basic Share | $0.32 | -$0.03 | |||||
| Income Loss From Continuing Operations | $7.0M | -$579.5K | |||||
| Other Nonoperating Expense |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stockholders Equity | $1.3M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.6M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $295.9K | -$14.3K | |
| Retained Earnings Accumulated Deficit | -$16.0M | ||
| Property Plant And Equipment Net | $524.5K | ||
| Prepaid Expense And Other Assets Current | $443.1K | ||
| Operating Lease Right Of Use Asset | $126.7K | ||
| Operating Lease Liability Noncurrent | $64.5K | ||
| Operating Lease Liability Current | $62.2K | ||
| Liabilities Noncurrent | $64.5K | ||
| Liabilities Current | $2.7M | ||
| Liabilities And Stockholders Equity | $4.5M | ||
| Liabilities | $2.8M | ||
| Common Stock Value | $20.0K | ||
| Assets Noncurrent | $1.4M | ||
| Assets Current | $3.1M | ||
| Assets | $4.5M | ||
| Additional Paid In Capital Common Stock | $16.5M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.1M | ||
| Accounts Payable And Accrued Liabilities Current | $2.7M | ||
| Repayments Of Related Party Debt | |||
| Other Assets Noncurrent | |||
| Deferred Costs | $638.9K | ||
| Finite Lived Intangible Assets Net | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | |||
| Intangible Assets Net Excluding Goodwill | $119.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $9.5M | $3.0M | $3.5M | $4.1M | $619.0K | $1.1M | $1.7M | -$497.8K | $196.8K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.6M | $2.7M | $2.9M | $5.2M | $2.6M | $2.6M | $2.6M | $2.7M | $2.8M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$247.4K | $39.0K | ||||||||
| Retained Earnings Accumulated Deficit | -$12.8M | -$19.6M | -$19.2M | -$18.5M | -$17.1M | |||||
| Property Plant And Equipment Net | $97.1K | $281.3K | $125.2K | $355.3K | $401.0K | |||||
| Prepaid Expense And Other Assets Current | $8.1M | $3.2M | $1.9M | $2.5M | $481.7K | |||||
| Operating Lease Right Of Use Asset | $21.1K | $42.8K | $41.7K | $180.9K | $241.3K | |||||
| Operating Lease Liability Noncurrent | $1.4K | $2.9K | $5.9K | $44.5K | $56.3K | |||||
| Operating Lease Liability Current | $19.7K | $27.9K | $35.8K | $138.4K | $233.7K | |||||
| Liabilities Noncurrent | $115.5K | $193.9K | $145.7K | $44.5K | $56.3K | |||||
| Liabilities Current | $1.3M | $3.0M | $10.1M | $4.1M | $3.8M | |||||
| Liabilities And Stockholders Equity | $10.9M | $6.2M | $13.7M | $8.3M | $4.5M | |||||
| Liabilities | $1.4M | $3.2M | $10.2M | $4.2M | $3.9M | |||||
| Common Stock Value | $21.6K | $21.6K | $21.6K | $21.6K | $20.0K | |||||
| Assets Noncurrent | $119.1K | $398.8K | $479.8K | $556.5K | $1.4M | |||||
| Assets Current | $10.7M | $5.8M | $13.2M | $7.7M | $3.1M | |||||
| Assets | $10.9M | $6.2M | $13.7M | $8.3M | $4.5M | |||||
| Additional Paid In Capital Common Stock | $21.3M | $21.3M | $21.3M | $21.3M | $16.5M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $874.7K | $1.3M | $1.3M | $1.3M | $1.3M | |||||
| Accounts Payable And Accrued Liabilities Current | $1.2M | $3.0M | $1.9M | $4.0M | $3.6M | |||||
| Repayments Of Related Party Debt | $22.2M | |||||||||
| Other Assets Noncurrent | $956.00 | $74.8K | $2.6K | |||||||
| Deferred Costs | $672.5K | |||||||||
| Finite Lived Intangible Assets Net | $20.3K | $119.0K | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $2.6M | $2.9M | $2.7M | $2.6M | ||||||
| Intangible Assets Net Excluding Goodwill | $50.5K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Payments To Acquire Property Plant And Equipment | $31.7K | $74.1K |
| Net Cash Provided By Used In Operating Activities | -$5.8M | -$2.1M |
| Net Cash Provided By Used In Investing Activities | -$31.7K | -$74.1K |
| Net Cash Provided By Used In Financing Activities | $5.9M | $1.9M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.7M | $279.4K |
| Increase Decrease In Accounts Payable And Other Operating Liabilities | -$117.7K | $479.6K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $218.3K | $319.3K |
| Proceeds From Issuance Initial Public Offering | $5.5M | -$85.4K |
| Increase Decrease In Other Noncurrent Assets | $83.0K | -$56.1K |
| Increase Decrease In Operating Lease Liability | -$23.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q3 2024 |
|---|---|---|
| Payments To Acquire Property Plant And Equipment | $1.8K | $20.0K |
| Net Cash Provided By Used In Operating Activities | -$610.3K | -$29.7K |
| Net Cash Provided By Used In Investing Activities | -$1.8K | -$20.0K |
| Net Cash Provided By Used In Financing Activities | $447.5K | $392.5K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $59.0K | $42.6K |
| Increase Decrease In Accounts Payable And Other Operating Liabilities | -$232.6K | $173.8K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$82.7K | -$303.8K |
| Proceeds From Issuance Initial Public Offering | -$16.8K | |
| Increase Decrease In Other Noncurrent Assets | -$8.3K | |
| Increase Decrease In Operating Lease Liability | $11.8K | $2.5K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Common Stock Shares Outstanding | ||
| Common Stock Shares Issued | 20.0M | |
| Weighted Average Number Of Shares Outstanding Basic | 20.5M | 20.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 20.5M | 20.0M |
| Earnings Per Share Diluted | $-0.16 | $-0.14 |
| Earnings Per Share Basic | $-0.16 | $-0.14 |
| Common Stock Shares Authorized | 400.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Shares Outstanding | 21.6M | 21.6M | 21.6M | 21.6M | 20.0M | 100.0M | 20.0M | 100.0M | ||
| Common Stock Shares Issued | 21.6M | 21.6M | 21.6M | 21.6M | 20.0M | 100.0M | 100.0M | |||
| Weighted Average Number Of Shares Outstanding Basic | 21.6M | 21.6M | 20.5M | 20.0M | 20.0M | 20.0M | 20.0M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 21.6M | 21.6M | 20.5M | 20.0M | 20.0M | 20.0M | 20.0M | |||
| Earnings Per Share Diluted | $0.31 | $-0.02 | $-0.07 | $-0.05 | $-0.01 | $-0.05 | $-0.01 | |||
| Earnings Per Share Basic | $0.31 | $-0.02 | $-0.07 | $-0.05 | $-0.01 | $-0.05 | $-0.01 | |||
| Common Stock Shares Authorized | 400.0M | 400.0M | 400.0M | 400.0M | 400.0M | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Investment Income Interest | $24.9K | $53.5K |
| Depreciation And Amortization | $343.8K | $399.6K |
| Stock Issued During Period Value New Issues | $4.9M | |
| Other Significant Noncash Transaction Value Of Consideration Received1 | $24.9K | |
| Gain Or Loss On Sale Of Stock In Subsidiary | ||
| Net Loss From Disposal Of Equipment |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Investment Income Interest | $9.2K | $448.00 | $15.4K | $10.00 | $104.00 | $20.0K |
| Depreciation And Amortization | $48.0K | $102.2K | ||||
| Stock Issued During Period Value New Issues | ||||||
| Other Significant Noncash Transaction Value Of Consideration Received1 | $448.00 | $10.00 | ||||
| Gain Or Loss On Sale Of Stock In Subsidiary | $7.3M | |||||
| Net Loss From Disposal Of Equipment | $61.00 |
Most recent annual filing with the SEC: October 8, 2025
Data sourced from SEC EDGAR public filings as of August 7, 2026.